SciBrunch Therapeutics
PrivateLast Round
Early Funding
Jan 30, 2026
Total Funding Raised
$63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SciBrunch Therapeutics is a biotechnology company that specializes in the discovery and development of innovative small-molecule oncology therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SciBrunch Therapeutics Comparables
Compare SciBrunch Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 祐森健恒生物医药（上海）有限公司 | 86% | |
| GenFleet Therapeutics | 86% | |
| Quanta Therapeutics | 80% |
For institutional investors. Book with your work email.
SciBrunch Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 30, 2026 | ||||
| Angel | Jun 5, 2025 |
For institutional investors. Book with your work email.
SciBrunch Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Early Funding |
| BioTrack Capital | Early Funding, Angel |
| LongRiver Investments | Angel, Early Funding |
| Hankang Capital | Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2026
$35M raised led by HighLight Capital.
- Jun 5, 2025
$28M round led by BioTrack Capital
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- licenses_technologySep 28, 2026
Under the closed agreement, SciBrunch Therapeutics Co., Ltd. grants MSD International exclusive worldwide rights to develop, manufacture and commercialize SPR2015, with a $400 million upfront payment and potential transaction value of $2.13 billion.
For institutional investors. Book with your work email.
SciBrunch Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SciBrunch Therapeutics's valuation, stock price, and market status.
Is SciBrunch Therapeutics a public or private company?
SciBrunch Therapeutics is a private company.
What is the current stock price of SciBrunch Therapeutics?
SciBrunch Therapeutics is a private company, so its shares have no public market price. Caplight tracks SciBrunch Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SciBrunch Therapeutics worth (valuation)?
Valuation information for SciBrunch Therapeutics is not publicly available.
Can I buy SciBrunch Therapeutics stock?
SciBrunch Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SciBrunch Therapeutics's last funding round?
SciBrunch Therapeutics's most recent funding round was Early Funding on January 30, 2026.
Who are the main investors in SciBrunch Therapeutics?
Key investors in SciBrunch Therapeutics include HighLight Capital, BioTrack Capital.
Will SciBrunch Therapeutics IPO soon?
No public IPO plans have been announced for SciBrunch Therapeutics.
How can I track SciBrunch Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in SciBrunch Therapeutics's shares on secondary markets.